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Matrix protein 1 (M1), the major structural protein of the avian influenza virus, plays a critical
role in regulation of viral RNA transcription via interaction with RNA and transportation of
RNP cores. Mutations in M1 have been frequently observed in the highly virulent avian
influenza H5N1 virus, which might be crucial to the pathogenic function. Here we report the
characterization of mutated peptides in M1 purified from highly pathogenic avian influenza
virus H5N1 by nanoelectrospray MS and MS/MS analyses on a quadrupole-time-of-flight
mass spectrometer (Q-TOFMS). The specificity of tandem mass spectrometry allowed the
identification of six amino acid (AA) substitutions in M1, including R95K, A166V, I168T,
N207S, N224S, and R230K. Two commonly observed modifications such as oxidation and
deamidation were accurately assigned in the protein. Bioinformatics analysis suggested some
relationship between the amino acid substitution and structural property of M1 protein.
Discussions on de novo sequencing of MS/MS spectra, especially in dealing with the AA
substitutions, were provided. (J Am Soc Mass Spectrom 2009, 20, 312–320) © 2009 American
Society for Mass SpectrometryThe influenza A virus causes human infectionevery year and continues to be a great threatagainst human health [1]. Among the various
subtypes of influenza A virus, avian H5N1, one of the
most highly pathogenic subtypes, has been found to
cross species barrier and to result in human infection in
recent years, including the 1997 and 2003 outbreaks in
Hong Kong [2]. The avian influenza virus can acquire
the ability for transmission to humans, mainly as a
result of adaptive mutation or genetic reassortment in
the strains. Matrix protein 1 (M1), the most abundant
structural protein in influenza A virus, consists of 252
amino acids and plays vital roles in the virus life cycle,
by regulating the transportation of ribonucleoprotein
(RNP) cores into or out of the nucleus [3, 4] and
controlling the termination of viral RNA synthesis
through RNA binding [5, 6]. Although being the most
conserved in the eight structural proteins, M1 has been
frequently observed to exhibit some mutations at sev-
eral sites, especially in avian H5N1 subtypes [7]. These
mutations often resulted in AA substitutions in the
primary structure of M1 and conferred some new
properties by altering the hydrophobicity as well as the
Address reprint requests to Dr. H. Chen, State Key Laboratory for Emerging
Infectious Diseases, Department of Microbiology, University of Hong Kong,
Hong Kong SAR, China. E-mail: hlchen@hkucc.hku.hk
Dr. Z. Cai, Department of Chemistry, Hong Kong Baptist University,
Kowloon Tong, Hong Kong SAR, China. E-mail: zwcai@hkbu.edu.hk
© 2009 American Society for Mass Spectrometry. Published by Elsevie
1044-0305/09/$32.00
doi:10.1016/j.jasms.2008.10.010secondary structures. It has also been indicated that
some mutations in certain sites in M1 were crucial to
pathogen function [8–10].
Analysis of antigens from influenza A virus by mass
spectrometry-based approaches was reported [11–13].
MALDI-TOFMS has been applied to identify epitopes
[11, 12] and post-translational modifications in influ-
enza antigens [13]. In recent years, several studies
reported mass spectrometric analysis of the mutation at
the protein level [14–17]. The advantage of soft ioniza-
tion techniques such as ESI and MALDI has allowed the
characterization of large biomolecules such as proteins
with high sensitivity and high accuracy. Using hemoglo-
bin variants as model protein, a variety of mutations were
successfully determined from MS analyses [14, 15]. A
novel cis double mutation in transthyretin was deter-
mined by using liquid chromatography-electrospray ion-
ization Fourier-transform ion-cyclotron-resonance mass
spectrometry [16]. Structural studies of two allelic wheat
glutenin subunits revealed a possible single amino acid
substitution in subunit 1Bx20 [17].
We herein identified six AA substitutions in M1
protein by using nanoelectrospray MS and MS/MS.
Two common modifications such as the oxidation at
methionines and deamidation at asparagines were
identified, and the modification sites were determined.
The obtained results indicated that nanoelectrospray
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terize the AA substitutions in M1 protein.
Experimental
Chemicals and Materials
HPLC grade ACN and methanol were from Fisher
(Fairlawn, NY). Sequencing grade trypsin was obtained
from Promega (Madison, WI). All other chemicals were
purchased from Sigma-Aldrich (St. Louis, MO). Avian
influenza virus A/Dk/HN/303/2004(H5N1) [18] was
propagated in a biosafety level 3 (BL-3) containment
facility. The genome of this strain of duck-origin influ-
enza virus was partially sequenced, which has been
preserved in State Key Laboratory for Emerging Infec-
tious Diseases, The University of Hong Kong.
Virus Cultivation
Avian influenza virus strain A/Dk/HN/303/2004
(H5N1) was harvested from allantoic fluid of chicken
embryos inoculated as 10-day old embryos and col-
lected 48 h later. Several serial passages in chicken
embryos were carried out to promote potential muta-
tions in virus. Finally, due to the highly pathogenicity
the virus possess, the virus-containing allantoic fluid
was inactivated with 0.03% formalin at 4 °C for 72 h. All
the experiments using the active virus were carried out
in a biosafety level 3 laboratory. The resulting inacti-
vated virus-containing allantoic fluid was then sub-
jected to further experiments.
Isolation of Virus by Ultracentrifugation
The virus-containing allantoic fluid was cleared from
large debris by centrifugation at 5000 g for 30 min. The
virus was collected from the supernatant by pelleting it
through a 5-step discontinuous gradient cushion con-
sisting of 20, 30, 40, 50, and 60% (wt/vol) sucrose, in a
Beckman Rotor SW40 Ti at 155,000 g (35,000 rpm) at
4 °C for 60 min. The resulting virus band between 40%
and 50% sucrose was carefully aspired out from the
SW40 tubes, followed by dilution with four volumes of
buffer (100 mM Tris, 10 mM MgCl2, pH 7.4) to form a
suspension. The virus was then applied to a 2-step
discontinuous gradient of 30% and 60% (wt/vol) su-
crose in Ultra clear SW60 tubes. Centrifugation was run
in a Beckman Rotor SW60 Ti at 38,800 rpm at 4 C for 60
min. The virus band was carefully collected, suspended
in and then freeze at 80 °C until use. The purity of the
virus was checked by SDS-PAGE.
Purification of M1 Protein
Matrix protein 1 was purified from A/Dk/HN/303/
2004(H5N1) by extraction with acidic chloroform-
methanol, as described by Gregoriades [19]. Protein
concentration was assayed by using the DC RCprotein assay kit (Bio-Rad, Hercules, CA, USA) with
BSA as a standard protein.
SDS-PAGE
Electrophoretic analyses were made in a Mini-Cell system
(Bio-Rad, Hercules, CA), and run in 12% tris-glycine-SDS
polyacrylamide gels with a 5% stacking gel at a constant
voltage setting of 100 V. Samples were prepared by
dilution with reducing sample loading buffer and boiling
at 95 °C for 5 min. After electrophoretic separation, the
gels were stained with colloidal Coomassie G250 and
scanned with a calibrated densitometer (GS800, Bio-Rad).
In-Solution Digestion
The protein sample (approximate 1.0 ug protein) was
prepared by dilution with equal volume of 25 mM
ammonium bicarbonate. After cysteines in M1 were
reduced and then alkylated, the sample was digested by
addition of sequencing grade modified porcine trypsin
(Promega, Madison, WI) in a trypsin to protein weight
ratio of 1:20. The mixture was left for 16 h or overnight
at 37 °C. The resulting tryptic peptide mixture was
stored at 20 °C until analysis.
Nanoelectrospray Mass Spectrometric Analysis
After desalted and purified by using ZipTip C18 pipette
tips (Millipore, Bedford, MA), the tryptic peptides were
analyzed on a quadrupole orthogonal acceleration time-
of-flight mass spectrometer (QSTAR; Applied Biosystems,
CA) equipped with an external nanoelectrospray ion
source (Protana A/S, Odense, Denmark). Renin substrate
was used to calibrate the instrument in the both MS and
MS/MSmode. Approximately 2 L of sample was loaded
into a PicoTip emitter (New Objective, Woburn, MA).
After the full mass spectra (parent ions) of tryptic peptides
were obtained in TOFMS mode, the charge states of the
peptides were assigned from the observed stable isotope
pattern. The parent ions of interest were then subject to
sequence analysis in product ion mode. In the product ion
mode acquisition, the resolution of Q1 was typically set at
a unit to insure the “purity” of the selected ions as long as
their intensity was high enough. Manual de novo se-
quencing of peptide tandem mass spectra was performed
with the aid of Pepsea (1.1) in Analyst QS 1.1 software
(MDS SCIEX, Concord, Canada).
Bioinformatics Analysis of the AA Substitutions
Identified in M1 Protein
Hydrophobicity values of the six AA substitutions were
calculated using ProtScale at ExPASy [20] with the
Kyte-Doolittle hydrophobicity scale. Secondary struc-
tures were predicted by using nnPREDICT [21]. Protein
stability changes upon mutations were predicted by
using I-Mutant 2.0 [22].
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Purification and Identification of M1 Protein
The cultivation of influenza virus in chicken embryos
was performed in several serial passages to improve the
chance of multigenic mutations [23]. The purification of
virus particles from allantoic fluid was carried out by
using ultracentrifugation in discontinuous sucrose
cushion. After pelleted in SW40 rotor, the virus particles
were subjected to a further purification in a small SW60
rotor to eliminate the possible contaminations from
allantoic fluid. Finally, M1 protein was extracted from
the purified virus by using acidic chloroform-methanol.
The purity of M1 protein was checked by SDS-PAGE
(Figure 1). The purified M1 protein was then subjected
to tryptic digestion and mass spectrometric analysis.
The tryptic digests were analyzed by using nanoelec-
trospray MS and MS/MS. After the MS spectrum of the
tryptic digests was recorded, the MS/MS analysis of
each peak was performed. With the aid of MASCOT
and Pepsea software, the peptides that had not under-
gone mutation were identified. A MASCOT score of 418
was obtained after the database searching against the
SwissProt database in the entries of other viruses on a
local Mascot server with the following parameters: one
missed cleavage, fixed cysteine carbamidomethylation,
and variable modifications such as asparagine/glu-
tamine deamidation and methionine oxidation. Careful
evaluation of the available data also allowed the iden-
tification of several mutated peptides. Accordingly, a
Figure 1. Purification ofM1 from allantoic fluid. The virus particles
were subject to ultracentrifugation in sucrose cushion to obtain
purified virus. M1 protein was extracted by acidic chloroform-
methanol from the purified virus. Samples were examined on a 12%
SDS-PAGE, followed by colloidal Coomassie G250 staining. Lane 1:
marker, lane 2: purified M1, lane 3: purified virus, lane 4: allantoic
fluid.total of 19 tryptic sequences (T1–T19) were identified,
which allowed the assignment of 14 unique peptide
sequences (Table 1). Sequence coverage of 70% was
obtained. By performing external calibration using re-
nin substrate, the Q-TOFMS analysis of the peptides
was achieved with mass accuracy within 27 ppm for the
m/z values of monoisotopic peaks.
Identification of R95K Substitution
Through the careful inspection of the available MS/MS
spectra, some spectra with very similar fragmentation
pattern and/or ion series were found and sorted into
individual groups. Two doubly charged ion peaks at
m/z 933.40 (T5) and 925.41 (T6), as well as three triply
charged ion peaks at m/z 622.61 (T5), 629.93 (T5), and
617.28 (T6) displayed similar MS/MS spectra. A com-
prehensive analysis of their MS/MS spectra allowed
determination of the primary sequence of the peaks at
m/z 617.28 and 925.41 as FVQNALDGDGDPNNMDK
(Figure 2). The peaks at m/z 622.61 and 933.40 were
identified as the peptide similar to that from m/z 617.28
and 925.41 except with the methionine oxidized. The
ion at m/z 629.93 was the sodium adduct of the ion at
m/z 622.61. Among these five signals observed, the ion
at m/z 622.61 displayed the highest intensity and thus
was selected for the subsequent investigation.
Through comparison with the expected sequence
in M1 protein, it was easy to locate the peptide
sequence in the residues from 79 to 95 in M1 as
FVQNALNGNGDPNNMDR. In Figure 2, the obtained
y-series ions enabled the determination of two deami-
dation modifications at N85 and N87 in the correspond-
ing peptide. Similar deamidation modifications were
not observed in the remaining three asparagines in this
peptide. It was noticed that the neighboring residues
next to the deamidated asparagines (N85 and N87) were
glycines. The observed pattern of deamidation was
consistent with the findings that glycine was observed
as the most common (N  1) neighboring residue in
proteins in which deamidation was established and
characterized [24, 25]. Accordingly, theoretical values of
the deamidated peptide FVQNALNGNGDPNNMDR
are m/z 631.93 and 947.41 for triply charged and doubly
charged species, respectively, considering that the me-
thionine is oxidized. The measured mass difference
between the expected and measured peptides was
28.02 and 27.96 Da, which was calculated from the
data of T5 with double charge and triple charge, respec-
tively. Two possible amino acid residues, namely V80,
R95, in T5 peptide may have a nominal mass shift of28
Da upon AA substitution: R¡K (28.01 Da), V¡A
(28.03 Da) and R¡Q (28.04 Da). Since Q was not a
typical C-terminal residue of tryptic peptides, AA sub-
stitution of R¡Q (28.04 Da) was first eliminated. So
the site upon mutation could be suggested at R95 (R¡K)
or V80 (V¡A).
The analysis of MS/MS spectrum of the ion peaks
was then performed to discriminate which one of the
fied m
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nostic y1 ion of m/z 147 for K as well as absence of y1 ion
of 175 for R in the MS/MS spectra of T5 and T6
Figure 2. ESI-MS/MS spectrum of triply char
mutated peptide (FVQNALN*GN*GDPNNM*D
Table 1. Summary of tryptic peptides identified in M1 protein f
Peak ID Peptide sequence
Charg
statu
T1 LEDVFAGK 2
T2 NTDLEVLM*EWLK 2
T3 TRPILSPLTK 3
T3 TRPILSPLTK 2
T4 GILGFVFTLTVPSER 3
T4 GILGFVFTLTVPSER 2
T5 FVQNALN*GN*GDPNNM*DK 3
T5 FVQNALN*GN*GDPNNM*DK 2
T5 FVQNALN*GN*GDPNNM*DKNa 3
T6 FVQNALN*GN*GDPNNMDK 3
T6 FVQNALN*GN*GDPNNMDK 2
T7 EITFHGAK 2
T8 M*GTVTTEVAFGLVCATCEQIADSQHR 3
T9 QMVTTTNPLIR 2
T10 QM*VTTTNPLIR 2
T11 MVLASTTAK 2
T12 M*VLASTTAK 2
T13 AM*EQM*AGSSEQAAEAM*EVASQAR 3
T14 AM*EQMAGSSEQAAEAM*EVASQAR 3
T15 AM*EQMAGSSEQAAEAMEVASQAR 3
T16 QMVQAMR 2
T17 TIGTHPSSSAGLK 2
T17 TIGTHPSSSAGLK 3
T18 DNLLENLQAYQK 2
T18 DNLLENLQAYQK 3
T19 M*GVQMQR 2
M: mono-oxidized methionine; N*: deamidated asparagine; the identitryptic digestion of M1 (M*: mono-oxidized methionsuggested that the tryptic peptide was very likely to
have a K residue at the C-terminus. Additionally, the
detection of b2 ion at m/z 247.14 and the a2 ion at m/z
T5 peak at m/z 622.61. It was identified as the
f an expected sequence (residues 79–95) from
the avian influenza virus [A/Dk/HN/303/2004(H5N1)]
Calculated m/z
(monoisotopic)
Measured m/z
(monoisotopic)
Error
(ppm) Residues
439.73 439.74 23 28–35
739.86 739.87 14 36–47
375.90 375.91 27 48–57
563.35 563.36 18 48–57
545.98 545.98 0 58–72
818.46 818.45 12 58–72
622.60 622.61 16 79–95
933.40 933.40 0 79–95
629.93 629.93 0 79–95
617.27 617.28 16 79–95
925.40 925.41 11 79–95
451.74 451.74 0 106–113
928.43 928.44 11 135–160
637.35 637.35 0 164–174
645.35 645.35 0 164–174
461.26 461.26 0 179–187
469.25 469.26 21 179–187
811.01 811.01 0 188–210
805.68 805.68 0 188–210
800.35 800.36 12 188–210
432.21 432.22 23 211–217
628.34 628.34 0 218–230
419.23 419.23 0 218–230
724.87 724.87 0 231–242
483.58 483.59 21 231–242
433.20 433.21 23 244–250
utated amino acid residues were highlighted.ged
K) orom
e
sine; N*: deamidated asparagine).
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residues in the peptide were FV, of which the theoret-
ical mass values were 247.14 and 219.15, respectively.
Therefore, the site upon mutation was confidently de-
termined at R95 (R¡K).
Identification of A166V and I168T Substitutions
Two doubly charged ion peaks T9 and T10 with m/z
637.35 and 645.35, respectively, were detected with a
very similar pattern of fragment ion series (Figure 3).
The produced fragment ion at m/z 175 indicated that the
corresponding peptides possibly ended with an R at the
C terminus. De novo sequencing of the spectra sug-
gested both peptides shared the same internal sequence
of VTTTN, which was deduced from the y-ion series
with m/z 1014.54, 915.48, 814.46, 713.41, 612.37, and
498.32. The inverse sequence NTTTV deduced from the
same ion series, which were considered as b-ions, was
less possible because the y-ion intensity of R-terminated
tryptic peptides would often be most prominent in the
spectra, particularly at the high end of the spectra. The
nominal mass difference between T9 and T10 was 16
Da, indicating that an oxidation, one of the most com-
monly observed modifications in peptides (usually at
methionine), might take place in T10. It should be
mentioned that the mass shift of 16 Da between T9 and
T10 might not be incurred by AA substitution due to
the empirical assumption that certain AA substitution
Figure 3. ESI-MS/MS spectrum of doubly cha
mutated peptide (QM*VTTTNPLIR) of an ex
digestion of M1 (M*: mono-oxidized methionine).resulted from gene mutation often exhibited in a homo-
geneous way.
The expected sequence of the tryptic peptide ranging
from 164 to 174 in M1 protein was QMATITNPLIR. The
theoretical m/z values of the doubly charged ions were
637.35 and 629.35 for the methionine-oxidized and
native peptides, respectively. Although the theoretical
value of 637.35 was the same as the measured value of
T9 (637.35), the MS/MS spectrum of T9 exhibited totally
different fragment ion series from those theoretically
deduced from QMATITNPLIR. Therefore, T9 did not
have the sequence of QMATITNPLIR.
Finally, the doubly charged ion peak T10 with m/z
645.35 was identified as the mutated peptide from the
expected sequence QMATITNPLIR (164–174) with two
mutated sites: A166 (A¡V) and I168 (I¡T). The combi-
nation of the AA substitution: A¡V (28.03 Da) and I¡T
(12.04 Da) resulted in a difference of nominal mass of
16 Da between the expected and the mutated peptides.
In addition to the y-ion series from y4 to y9, other
characteristic ions such as b2, b2-NH3, b3, b3-NH3, and
b4-NH3 were also readily assigned, confirming the
identification. T9 was then identified as the same se-
quence with T10, but with the notoxidized methionine.
Identification of N207S Substitution
The expected sequence of the peptide ranging from 188 to
210 in M1 protein was AMEQMAGSSEQAAEAMEVAN-
T10 peak at m/z 645.35. It was identified as the
d sequence (residues 164–174) from trypticrged
pecte
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ions were 809.35, 814.68, and 820.01 for the one, two,
and three oxidized methionines, respectively. The
peaks of T15, T14, and T13 with m/z 800.36, 805.68 and
811.01, respectively, were identified as the sequence of
AMEQMAGSSEQAAEAMEVANQAR with various ox-
idative states of methionines. However, a difference of
nominal mass of27 Da was observed for T15, T14, and
T13, compared with the same sequence peptide with
one, two, and three oxidized methionines. Two differ-
ent types of AA substitutions with the nominal mass
shift of 27 Da upon AA substitution were possible,
namely N¡S (27.01 Da), K¡T (27.05 Da). Since one
N and no K residue was presented in the peptide se-
quence, the mutation site could be determined at the N
residue (N¡S). The clearly assigned y-ion series from y1
to y13 confirmed the mutation at the position (Figure 4).
Identification of N224S and R230 Substitutions
The isotope pattern in MS spectra and the fragmenta-
tion pattern in MS/MS spectra of the both ions at m/z
628.34 and m/z 419.23 demonstrated that they were
doubly charged and triply charged ions of a same
peptide (T17), respectively. De novo sequencing of the
MS/MS spectra of T17 suggested a partial sequence of
PSSSAG(L/I)K (Figure 5), which was very similar to the
expected sequence of PNSSAGLR (223–230) in M1 pro-
tein. The expected sequence of the tryptic peptide
containing PNSSAGLR was TIGTHPNSSAGLR (218–
Figure 4. ESI-MS/MS spectrum of triply char
mutated peptide (AM*EQM*AGSSEQAAEAM
188–210) from tryptic digestion of M1 (M*: mono-ox230) with a theoretical m/z values at 655.84 and 437.56
for doubly charged and triply charged ions, respec-
tively. Therefore, it could readily assign the sequence of
T17 as a mutated sequence of TIGTHPNSSAGLR. The
nominal mass shift between the mutated and expected
peptide was 55 Da. The only type of AA substitution
exhibiting the nominal mass shift of 55 Da was R¡T
(55.05 Da), which was unlikely because T was not a
typical cleavage site of trypsin. Therefore, combination
of multiple AA substitutions was investigated for this
peptide. Similar to the MS/MS spectrum of T5 and T6,
a fragment ion at m/z 147 was observed and no signal at
m/z 175 was found, suggesting that the AA substitution
of R¡K (28.01 Da) took place at the C terminus. The
additional mass difference of 27 Da might result from
one of the two potential AA substitutions, namely N¡S
(27.01 Da) or K¡T (27.05 Da). Because only one N
was present in the expected peptide sequence, the AA
substitution N¡S (27.01 Da) at N224 could be readily
deduced. The suggestion was supported by the detection
of y ion series in MS/MS spectra of the corresponding
peptide. Similar to the identification of T9 and T10, T17
was identified as a tryptic peptide TIGTHPSSSAGLKwith
two AA substitutions in M1 protein.
In summary, six AA substitutions were identified by
nanoelectrospray MS and MS/MS in four tryptic pep-
tides of M1 protein of avian influenza H5N1 virus
(Figure 6). Noticeably, none of the peaks of the corre-
sponding expected peptides of these four mutated
peptides were detected, indicating that the AA substi-
13 peak at m/z 811.01. It was identified as the
SQAR) of an expected sequence (residuesged T
*EVAidized methionine).
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take place in a homogenous way. This phenomenon
was different from the modification on amino residues
such as deamidation or oxidation, which showed sev-
eral variants of the same peptide with different status of
modification. The MS/MS spectra of T9 and T10 exhib-
ited similar fragmentation patterns, suggesting they
might share the same or very similar sequence.
Therefore, the mass difference of 16 Da between these
two peptides was subjectively determined as the
modification occurring at certain residue (oxidation
at methionine), rather than AA substitution. Similar
fragmentation was also found in the analysis of T13,
T14, and T15. If a group of peaks with very similar
fragmentation patterns were detected in tryptic pep-
tides, the difference in nominal mass should not be
attributed to AA substitution, but to probable modi-
fications. When the AA-substituted peptide was de-
tected, the corresponding native peptide was usually
not found in the same sample. AA substitutions could
be usually detected in variants of the same protein
Figure 5. ESI-MS/MS spectrum of triply char
mutated peptide (TIGTHPSSSAGLK) of an e
digestion of M1.
10 20 30 40 50 60
MSLLTEVETY   VLSIIPSGPL    KAEIAQKLED   VFAGKNTDLE    ALMEWLKTRP  ILSPLTKGIL 
70 80 90 100 110 120
GFVFTLTVPS   ERGLQRRRFV   QNALNGNGDP  NNMDRAVKLY   KKLKREITFH  GAKEVALSYS 
130 140 150 160 170         180
TGALASCMGL  IYNRMGTVTT     EVAFGLVCAT   CEQIADSQHR    SHRQMAT ITN  PLI RHENRMV 
190 200 210 220 230 240
LASTTAKAME  QMAGSSEQAA   EAMEVANQAR  QMVQAMRTIG THPNSSAGLR DNLLENLQAY
250
QKRMGVQMQR FK
K
V  T
K SS
Figure 6. Summary of the mutation sites in M1 protein of avian
influenza virus [A/Dk/HN/303/2004(H5N1)] identified by using
nanoelectrospray MS and MS/MS.originating from individual samples with different
physiological status. This observation might be useful
in de novo sequencing of MS/MS spectra, especially
in the analysis of real samples underlying possible
AA substitution.
Analysis of antigens from influenza A virus by
mass spectrometry-based approaches was reported
[11–13]. An immunoaffinity-coupled mass spectro-
metric method was developed and used to identify an
antigenic epitope to a monoclonal antibody against
hemagglutinin (HA), one of the envelope proteins in the
viral particles [11, 12]. By using MALDI-TOFMS, acyla-
tion modification in the C-terminal HA2 was investi-
gated [13]. In the present study, nanoelectrospray MS
and MS/MS were employed to analyze the primary
structure of the M1 from a highly pathogenic avian
influenza A (H5N1) strain through the de novo se-
quencing of peptides. During nanospray ESI-MS anal-
ysis of mutated peptides, mass accuracy lower than 27
ppm was achieved with external calibration. At this
level of mass accuracy, some AA substitutions could
not be confidently assigned without MS/MS analysis.
For the identification of R95K in the peptide T5 and T6,
for example, the theoretical mass shift of the two
possible AA substitutions was 28.01 and 28.03 Da
for the mutation of R¡K and V¡A, respectively. Be-
cause the measured mass shift was 28.02 Da between
the expected and mutated T5 peptide, it was impossible
to determine whether the mutation was R¡K or V¡A
in the peptide. However, if mass accuracy of 1 to 2 ppm
could be achieved, for example by FT-MS, assignment
17 peak at m/z 419.23. It was identified as the
ed sequence (residues 218–230) from trypticged T
xpectof the different AA substitution could be possible.
energ
e stab
319J Am Soc Mass Spectrom 2009, 20, 312–320 MAPPING AMINO ACID SUBSTITUTIONS IN MATRIX PROTEIN 1Changes in Hydrophobicity, Secondary Structure,
and Protein Stability
Among the six mutations identified, I168T was found to
be a non-synonymous mutation, resulting in the change
from hydrophobic to hydrophilic at the mutation site.
The other five mutations, namely R95K, A166V, N207S,
N224S, and R230K, were synonymous and would not
have the change. Prediction for the secondary structure
by nnPREDICT software indicated that there was a
change from random coil to extended strand in the
secondary structure at residue of 166 upon the substi-
tution of A to V. The other five AA substitutions did not
alter the secondary structure at the respective site.
Changes of protein stability upon the individual muta-
tions were also evaluated by using I-Mutant 2.0 soft-
ware. Estimation of protein stability was performed by
calculating the free-energy change (G) upon muta-
tion. The result showed that each of the six AA substi-
tutions exhibited a decrease in free-energy and decrease
in the stability of M1 protein (Table 2).
Conclusions
Six AA substitutions in avian influenza H5N1 virus
matrix protein 1 located in four tryptic peptides of the
protein were identified from the nanoelectrospray
Q-TOFMS and MS/MS analyses, of which some rele-
vance between the changes in protein structures and the
AA substitutions were revealed from the bioinformatics
analyses. Mass spectrometric analyses also allowed the
site assignment of some commonly observed modifica-
tions such as oxidation (M) and deamidation (N) in M1
protein. Among the four mutated peptides identified in
the tryptic digest of M1, two peptides bearing only one
AA substitution were initially identified. A great ben-
efit can be derived from significant improvement of
measurement accuracy (1 to 2 ppm) in analyzing
peptides bearing only one AA substitution when a
high-resolution mass spectrometer such as FT-MS is
used. But for the determination of the two peptides
bearing two AA substitutions, MS analysis with high-
resolution mass measurement alone is insufficient,
whereas the interpretation of MS/MS fragmentations
Table 2. Summary of changes in hydrophobicity, secondary stru
in M1 from the avian influenza virus [A/Dk/HN/303/2004(H5N
Residue position
of substitution
Change of
residue
Change in hydrophobic
(Kyte-Doolittle)
95 R¡K 0.800¡0.733
166 A¡V 0.878¡1.189
168 I¡T 0.222¡0.089
207 N¡S 0.978¡0.678
224 N¡S 1.067¡0.767
230 R¡K 0.056¡0.122
H: alpha helix; E: extended strand; C: random coil;  G*:  G (free
sequence) in kcal/mol;  G  0: decrease stability;  G  0: increaswill play a pivotal role. The specificity of MS/MSenables the de novo sequencing of the mutated pep-
tides, which may be useful for investigating various
virus species with high mutability, such as the influenza
virus.
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